[1] Simonetto, M., Infante, M., Sacco, R. L., Rundek, T., & Della-Morte, D. (2019). A Novel Anti-Inflammatory Role of Omega-3 PUFAs in Prevention and Treatment of Atherosclerosis and Vascular Cognitive Impairment and Dementia. Nutrients, 11(10), 2279.
[2] Shidfar, F., Keshavarz, A., Hosseyni, S., Ameri, A., & Yarahmadi, S. (2008). Effects of omega-3 fatty acid supplements on serum lipids, apolipoproteins and malondialdehyde in type 2 diabetes patients. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 14(2), 305–313.
[3] Deinema, L. A., Vingrys, A. J., Wong, C. Y., Jackson, D. C., Chinnery, H. R., & Downie, L. E. (2017). A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease. Ophthalmology, 124(1), 43–52.
[4] Calder P. C. (2013). Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?. British journal of clinical pharmacology, 75(3), 645–662.
[5] NIH, Dietary Supplement Fact Sheets |